江苏医药产业创新效率及其影响因素研究

发布时间：2018-06-30 05:41

本文选题：医药产业 + 创新效率　；参考：《南京工业大学》2013年硕士论文

【摘要】：医药产业是战略性新兴产业培育发展的对象之一，有着广阔的发展前景。江苏省不仅是我国经济强省，也是医药产业大省，目前已经形成了连云港、苏州等五大医药产业集聚区，区域内已聚集一大批在国内具有一定影响力的优势企业。从整体上来看，虽然江苏医药产业在其规模以及产出能力上已经有了较为明显的提升，但是创新能力并没有随之增强，许多产品的生产都是以仿制为主，很少企业能够生产出具有自主知识产权的全新创新药品或是医疗设备，目前为止尚无一个在国际上有重要影响力的创新药物问世。由此可见，与国外相比，江苏医药产业创新水平还存在着较大的差距，主要体现在创新投入的不足以及创新资源配置效率的低下，而后者是制约江苏医药产业创新发展的主要原因。首先，本文从国内外关于创新效率理论的角度出发，回顾先前的创新效率内涵以及效率测定方法，以此作为本文的理论研究基础。其次，对先前学者关于产业创新效率测算及创新效率影响因素的研究进行总结评述。基于先前研究的不足，本文运用随机前沿分析方法（SFA法）测算江苏医药产业创新效率，并对创新效率影响因素进行深入分析，先前研究的影响因素主要包括企业规模、市场竞争、对外开放等外部宏观因素，缺乏从主观因素角度对医药产业创新效率的影响研究。鉴于先前研究缺陷，本文结合医药产业特性以及江苏自身发展状况，从产学研合作以及产业集聚两个角度来研究对江苏医药产业创新效率的影响，在理论分析的基础上提出假设，并运用多元回归分析方法，对统计数据进行定量分析，对假设进行验证。通过理论分析与实证分析的结合，本文得出如下结论与建议：一是从短期来讲，产学研合作各方由于彼此之间的沟通、信任存在一定的问题，阻碍了合作创新的顺利实施，产学研合作创新对医药产业创新效率的提升有负面影响。二是从长期来讲，随着时间的推移，主体间能够从整体利益角度出发，合理分配创新资源，发挥各自的最大优势，在有限的创新投入下能够获得较多的创新产出，，产学研合作创新对医药产业创新效率提升有正向影响，三是产业集聚利于知识、技术等信息的无意识扩散，产业集聚度越高越有利于产业创新效率的提升。
[Abstract]:Pharmaceutical industry is one of the targets of strategic emerging industries, and has a broad development prospect. Jiangsu Province is not only a strong economic province of our country, but also a big province of pharmaceutical industry. At present, it has formed five pharmaceutical industry agglomeration areas, such as Lianyungang, Suzhou and so on. On the whole, although Jiangsu's pharmaceutical industry has obviously improved its scale and output capacity, but its innovation ability has not been enhanced, many products are produced mainly in imitation. Few companies are able to produce new and innovative drugs or medical devices with their own intellectual property rights. So far, no innovative drugs with important influence in the world have come out. Therefore, compared with foreign countries, there is still a big gap in the innovation level of Jiangsu pharmaceutical industry, mainly reflected in the shortage of innovation input and the low efficiency of the allocation of innovative resources. The latter is the main reason for restricting the innovation and development of Jiangsu pharmaceutical industry. First of all, from the point of view of innovation efficiency theory at home and abroad, this paper reviews the previous innovation efficiency connotation and efficiency measurement methods, which is the theoretical basis of this paper. Secondly, the author summarizes the previous researches on the measurement of industrial innovation efficiency and the influencing factors of innovation efficiency. Based on the shortcomings of previous studies, this paper uses the stochastic frontier analysis (SFA) method to measure the innovation efficiency of Jiangsu pharmaceutical industry, and analyzes the influencing factors of innovation efficiency. The external macro factors, such as market competition and opening to the outside world, lack the research on the influence of subjective factors on the innovation efficiency of pharmaceutical industry. In view of the defects of previous research, this paper studies the effects on the innovation efficiency of pharmaceutical industry in Jiangsu from the perspectives of industry-university-research cooperation and industrial agglomeration, combining with the characteristics of pharmaceutical industry and the development of Jiangsu itself. On the basis of theoretical analysis, the hypothesis is put forward, and the statistical data are quantitatively analyzed by using the method of multiple regression analysis, and the hypothesis is verified. Through the combination of theoretical analysis and empirical analysis, this paper draws the following conclusions and suggestions: first, in the short term, there are certain problems in trust between the parties in the industry-university-research cooperation due to their communication with each other. It hinders the smooth implementation of cooperative innovation, and the innovation of industry, university and research has a negative effect on the improvement of innovation efficiency of pharmaceutical industry. Second, in the long run, with the passage of time, the main bodies can reasonably allocate innovative resources from the perspective of the overall interests, give play to their respective greatest advantages, and can obtain more innovation output under the limited innovation input. The innovation of industry-university-research cooperation has a positive effect on the innovation efficiency of pharmaceutical industry. Third, industrial agglomeration is conducive to the unconscious diffusion of knowledge and technology, and the higher the degree of industrial agglomeration is, the better the industrial innovation efficiency is.
【学位授予单位】：南京工业大学
【学位级别】：硕士
【学位授予年份】：2013
【分类号】：F273.1;F426.72

【参考文献】